Cymat Technologies Ltd.
CYMHF
$0.07
$0.00-5.00%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.30M | 1.36M | 2.67M | 2.68M | 2.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.30M | 1.36M | 2.67M | 2.68M | 2.05M |
| Cost of Revenue | 1.32M | 1.57M | 2.32M | 2.06M | 1.74M |
| Gross Profit | -18.90K | -212.60K | 358.30K | 620.50K | 300.80K |
| SG&A Expenses | 2.00M | 1.84M | 1.92M | 1.90M | 2.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.46M | 3.54M | 4.43M | 4.16M | 4.00M |
| Operating Income | -2.16M | -2.18M | -1.75M | -1.48M | -1.96M |
| Income Before Tax | -2.90M | -2.88M | -2.41M | -2.12M | -2.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.90 | -2.88 | -2.41 | -2.12 | -2.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.90M | -2.88M | -2.41M | -2.12M | -2.47M |
| EBIT | -2.16M | -2.18M | -1.75M | -1.48M | -1.96M |
| EBITDA | -1.93M | -1.94M | -1.47M | -1.18M | -1.63M |
| EPS Basic | -0.04 | -0.04 | -0.04 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.04 | -0.04 | -0.04 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 291.72M | 271.42M | 259.58M | 262.51M | 262.46M |
| Average Diluted Shares Outstanding | 291.72M | 271.42M | 259.58M | 262.51M | 262.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |